Cytomegalovirus‐specific T‐cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib
Authors:
Open Access
- 16 August 2021
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 195 (4) , 637-641
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled TrialsClinical Lymphoma Myeloma and Leukemia, 2020
- Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysisAmerican Journal of Transplantation, 2019
- Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid CancerClinical Infectious Diseases, 2018
- Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignanciesEuropean Journal of Haematology, 2018
- Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate ImmunityFrontiers in Immunology, 2017
- CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemiaBlood, 2014
- Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemiaDiagnostic Microbiology and Infectious Disease, 2013
- Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant RecipientsJournal of Clinical Microbiology, 2008
- Enumeration of cytomegalovirus-specific interferon CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infectionHaematologica, 2008
- Epidemiologic Analysis of Reactivated Cytomegalovirus Antigenemia in Patients with CancerJournal of Clinical Microbiology, 2007